| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $0 ) |
| | 2025 | 2024 | VERRA THERAPEUTICS, INC. | 1939 E SHORE DR STE 5 | LANSING | NY | 14882-8986 | TOMPKINS | USA | R44HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 000 | 3 | NIH | 9/8/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $635,475 ) |
| | 2024 | 2024 | VERRA THERAPEUTICS LLC | 127 ASBURY RD | LANSING | NY | 14882-8914 | TOMPKINS | USA | R44HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 002 | 3 | NIH | 5/25/2024 | $0 |
| | 2024 | 2024 | VERRA THERAPEUTICS LLC | 127 ASBURY RD | LANSING | NY | 14882-8914 | TOMPKINS | USA | R44HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 001 | 3 | NIH | 11/29/2023 | $635,475 |
| | 2024 | 2023 | VERRA THERAPEUTICS LLC | 127 ASBURY RD | LANSING | NY | 14882-8914 | TOMPKINS | USA | R44HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 000 | 2 | NIH | 10/31/2023 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $1,364,498 ) |
| | 2023 | 2023 | VERRA THERAPEUTICS LLC | 127 ASBURY RD | LANSING | NY | 14882-8914 | TOMPKINS | USA | R44HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 001 | 2 | NIH | 2/17/2023 | $0 |
| | 2023 | 2023 | VERRA THERAPEUTICS, LLC | 127 ASBURY RD | ITHACA | NY | 14882-8914 | TOMPKINS | USA | R44HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 000 | 2 | NIH | 12/15/2022 | $1,364,498 |
|
| Issue Date FY: 2022 ( Subtotal = $46,563 ) |
| | 2022 | 2019 | VERRA THERAPEUTICS, LLC | 127 ASBURY RD | ITHACA | NY | 14882-8914 | TOMPKINS | USA | R43HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 001 | 1 | NIH | 12/7/2021 | -$55 |
| | 2022 | 2019 | VERRA THERAPEUTICS, LLC | 127 ASBURY RD | ITHACA | NY | 14882-8914 | TOMPKINS | USA | R43HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 000 | 1 | NIH | 11/22/2021 | $46,618 |
|
| Issue Date FY: 2021 ( Subtotal = -$46,618 ) |
| | 2021 | 2019 | VERRA THERAPEUTICS, LLC | 127 ASBURY RD | ITHACA | NY | 14882-8914 | TOMPKINS | USA | R43HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 000 | 1 | NIH | 9/22/2021 | -$46,618 |
|
| Issue Date FY: 2019 ( Subtotal = $391,023 ) |
| | 2019 | 2019 | VERRA THERAPEUTICS, LLC | 127 ASBURY RD | ITHACA | NY | 14882-8914 | TOMPKINS | USA | R43HL149580 | A Disease-Modifying Protein Therapeutic for the Treatment of COPD | 000 | 1 | NIH | 9/13/2019 | $391,023 |
|
|
